Search Results - "Toraya, Seiko"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Stimulating antitumor immunity with nanoparticles by Sheen, Mee Rie, Lizotte, Patrick H., Toraya-Brown, Seiko, Fiering, Steven

    “…A variety of strategies, have been applied to cancer treatment and the most recent one to become prominent is immunotherapy. This interest has been fostered by…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21 by Nishida, Jun, Shichino, Shigeyuki, Tsukui, Tatsuya, Hoshino, Mayumi, Okada, Tomoko, Okada, Kyoko, Yi, Yuri, Toraya-Brown, Seiko, Mochizuki, Miho, Koizumi, Ryouta, Ishii-Schrade, Katrin, Denda-Nagai, Kaori, Irimura, Tatsuro

    “…Mucin 21(Muc21)/epiglycanin is expressed on apical surfaces of squamous epithelia and has potentially protective roles, which are thought to be associated with…”
    Get full text
    Journal Article
  8. 8

    Toward Localized In Vivo Biomarker Concentration Measurements by Xiaojuan Zhang, Reeves, Daniel, Yipeng Shi, Gimi, Barjor, Nemani, Krishnamurthy, Perreard, Irina M., Toraya-Brown, Seiko, Fiering, Steven, Weaver, John B.

    Published in IEEE transactions on magnetics (01-02-2015)
    “…We know a great deal about the biochemistry of cells because they can be isolated and studied. The biochemistry of the much more complex in vivo environment is…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Local tumour hyperthermia as immunotherapy for metastatic cancer by Toraya-Brown, Seiko, Fiering, Steven

    Published in International journal of hyperthermia (01-12-2014)
    “…Abstract Local tumour hyperthermia for cancer treatment is currently used either for ablation purposes as an alternative to surgery or less frequently, in…”
    Get more information
    Journal Article
  11. 11

    CD4+ T Cells Elicit Host Immune Responses to MHC Class II− Ovarian Cancer through CCL5 Secretion and CD40-Mediated Licensing of Dendritic Cells by Nesbeth, Yolanda C., Martinez, Diana G., Toraya, Seiko, Scarlett, Uciane K., Cubillos-Ruiz, Juan R., Rutkowski, Melanie R., Conejo-Garcia, Jose R.

    Published in The Journal of immunology (1950) (15-05-2010)
    “…Abstract T cell adoptive transfer strategies that have produced clinical remissions against specific tumors have so far produced disappointing results against…”
    Get full text
    Journal Article
  12. 12

    Modulating therapeutic antitumor T cell immunity with MicroRNAs (156.21) by Rutkowski, Melanie, Nesbeth, Yolanda, Toraya, Seiko, Scarlett, Uciane, Jacobs, Ana, Conejo-Garcia, Jose

    Published in The Journal of immunology (1950) (01-04-2011)
    “…Abstract MicroRNAs are attractive candidates for enhancing the therapeutic effectiveness of adoptive T cell therapy, although overcoming tumor-induced…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Local hyperthermia and nanoparticle targeting for cancer immunotherapy by Brown, Seiko Toraya

    Published 2014
    “…Local hyperthermia treatment for cancer has been used clinically in combination with and to enhance the efficacy of traditional treatments such as chemotherapy…”
    Get full text
    Dissertation
  15. 15

    CD4+ T CELLS ELICIT HOST IMMUNE RESPONSES TO MHC-II− OVARIAN CANCER THROUGH CCL5 SECRETION AND CD40-MEDIATED LICENSING OF DENDRITIC CELLS by Nesbeth, Yolanda C., Martinez, Diana G., Toraya, Seiko, Scarlett, Uciane K., Cubillos-Ruiz, Juan R., Rutkowski, Melanie R., Conejo-Garcia, Jose R.

    Published in The Journal of immunology (1950) (16-04-2010)
    “…T cell adoptive transfer strategies that have produced clinical remissions against specific tumors have so far produced disappointing results against ovarian…”
    Get full text
    Journal Article
  16. 16

    Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy by Toraya-Brown, Seiko, Sheen, Mee Rie, Baird, Jason R, Barry, Stephen, Demidenko, Eugene, Turk, Mary Jo, Hoopes, P Jack, Conejo-Garcia, Jose R, Fiering, Steven

    Published in Integrative biology (Cambridge) (01-01-2013)
    “…Nanotechnology has great potential to produce novel therapeutic strategies that target malignant cells through the ability of nanoparticles to get access to…”
    Get full text
    Journal Article
  17. 17

    CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells by Nesbeth, Yolanda C, Martinez, Diana G, Toraya, Seiko, Scarlett, Uciane K, Cubillos-Ruiz, Juan R, Rutkowski, Melanie R, Conejo-Garcia, Jose R

    Published in The Journal of immunology (1950) (15-05-2010)
    “…T cell adoptive transfer strategies that have produced clinical remissions against specific tumors have so far produced disappointing results against ovarian…”
    Get full text
    Journal Article
  18. 18

    Quantification of magnetic nanoparticles with low frequency magnetic fields: compensating for relaxation effects by Weaver, John B, Zhang, Xiaojuan, Kuehlert, Esra, Toraya-Brown, Seiko, Reeves, Daniel B, Perreard, Irina M, Fiering, Steven

    Published in Nanotechnology (16-08-2013)
    “…Quantifying the number of nanoparticles present in tissue is central to many in vivo and in vitro applications. Magnetic nanoparticles can be detected with…”
    Get more information
    Journal Article
  19. 19

    Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo by Ndong, Christian, Toraya-Brown, Seiko, Kekalo, Katsiaryna, Baker, Ian, Gerngross, Tillman U, Fiering, Steven N, Griswold, Karl E

    Published in International journal of nanomedicine (01-04-2015)
    “…Active molecular targeting has become an important aspect of nanoparticle development for oncology indications. Here, we describe molecular targeting of iron…”
    Get full text
    Journal Article
  20. 20

    Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapyElectronic supplementary information (ESI) available. See DOI: 10.1039/c2ib20180a by Toraya-Brown, Seiko, Sheen, Mee Rie, Baird, Jason R, Barry, Stephen, Demidenko, Eugene, Turk, Mary Jo, Hoopes, P. Jack, Conejo-Garcia, Jose R, Fiering, Steven

    Published 17-12-2012
    “…Nanotechnology has great potential to produce novel therapeutic strategies that target malignant cells through the ability of nanoparticles to get access to…”
    Get full text
    Journal Article